Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 297, Issue 1, 2009, Pages

  Dufour, Sylvie ^a   Lebon, Vincent ^a,b   Shulman, Gerald I ^a   Petersen, Kitt Falk ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

Epinephrine; Gluconeogenesis; Humans; Net hepatic glycogenolysis

Indexed keywords

ADRENALIN; GLUCAGON; GLUCOSE; INSULIN; SOMATOSTATIN;

ADRENALIN BLOOD LEVEL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; FEMALE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; GLYCOGENOLYSIS; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LIVER; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; EPINEPHRINE; FEMALE; GLUCAGON; GLUCONEOGENESIS; GLYCOGENOLYSIS; HUMANS; INSULIN; LACTIC ACID; LIVER; MALE; YOUNG ADULT;

EID: 67650079659     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00222.2009     Document Type: Article

References (19)

1. Barthel A, Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 285: E685-E692, 2003.
2. Chen X, Iqbal N, Boden G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103: 365-372, 1999.
3. Cori CF, Schmidt G, Cori GT. The synthesis of a polysaccharide from glucose-1-phosphate in muscle extract. Science 89: 464-465, 1939.
4. Hutson NJ, Brumley FT, Assimacopoulos FD, Harper SC, Exton JH. Studies on the alpha-adrenergic activation of hepatic glucose output. I. Studies on the alpha-adrenergic activation of phosphorylase and gluconeogenesis and inactivation of glycogen synthase in isolated rat liver parenchymal cells. J Biol Chem 251: 5200-5208, 1976.
5. Liljenquist JE, Bomboy JD, Lewis SB, Sinclair-Smith BC, Felts PW, Lacy WW, Crofford OB, Liddle GW. Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men. J Clin Invest 53: 198-204, 1974.
6. Magnusson I, Rothman DL, Gerard DP, Katz LD, Shulman GI. Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes 44: 185-189, 1995.
7. Mayerson AB, Hundal RS, Dufour S, Lebon V, Befroy D, Cline GW, Enocksson S, Inzucchi SE, Shulman GI, Petersen KF. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 51: 797-802, 2002.
8. Miles J, Glasscock R, Aikens J, Gerich J, Haymond M. A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res 24: 96-99, 1983.
9. Petersen KF, Laurent D, Rothman DL, Cline GW, Shulman GI. Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest 101: 1203-1209, 1998.
10. Petersen KF, Price T, Cline GW, Rothman DL, Shulman GI. Contribution of net hepatic glycogenolysis to glucose production during the early postprandial period. Am J Physiol Endocrinol Metab 270: E186-E191, 1996.
11. Petersen KF, Price TB, Bergeron R. Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of type 1 diabetes. J Clin Endocrinol Metab 89: 4656-4664, 2004.
12. Postic C, Dentin R, Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab 30: 398-408, 2004.
13. Radziuk J, Norwich KH, Vranic M. Experimental validation of measurements of glucose turnover in nonsteady state. Am J Physiol Endocrinol Metab Gastrointest Liver Physiol 234: E84-E93, 1978.
14. Rizza R, Haymond M, Cryer P, Gerich J. Differential effects of epinephrine on glucose production and disposal in man. Am J Physiol Endocrinol Metab 237: E356-E362, 1979.
15. Rothman DL, Magnusson I, Katz LD, Shulman RG, Shulman GI. Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 254: 573-576, 1991.
16. Sacca L, Vigorito C, Cicala M, Corso G, Sherwin RS. Role of gluconeogenesis in epinephrine-stimulated hepatic glucose production in humans. Am J Physiol Endocrinol Metab 245: E294-E302, 1983.
17. Shiota M, Moore MC, Galassetti P, Monohan M, Neal DW, Shulman GI, Cherrington AD. Inclusion of low amounts of fructose with an intraduodenal glucose load markedly reduces postprandial hyperglycemia and hyperinsulinemia in the conscious dog. Diabetes 51: 469-478, 2002.
18. Shulman GI, Liljenquist JE, Williams PE, Lacy WW. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon. J Clin Invest 62: 487-491, 1978.
19. Stevenson RW, Steiner KE, Connolly CC, Fuchs H, Alberti KG, Williams PE, Cherrington AD. Dose-related effects of epinephrine on glucose production in conscious dogs. Am J Physiol Endocrinol Metab 260: E363-E370, 1991.